Sarana Meditama Metropolitan (SAME) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sarana Meditama Metropolitan (SAME) has a cash flow conversion efficiency ratio of 0.038x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp157.73 Billion ≈ $9.24 Million USD) by net assets (Rp4.17 Trillion ≈ $244.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sarana Meditama Metropolitan - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Sarana Meditama Metropolitan's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Sarana Meditama Metropolitan total liabilities for a breakdown of total debt and financial obligations.
Sarana Meditama Metropolitan Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sarana Meditama Metropolitan ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Samudera Indonesia Tbk
JK:SMDR
|
-0.044x |
|
Ratchthani Leasing Public Company Limited
BK:THANI
|
0.127x |
|
Mount Gibson Iron Ltd
AU:MGX
|
0.026x |
|
Motech Industries Co Ltd
TWO:6244
|
0.132x |
|
T&L Co. Ltd
KQ:340570
|
0.049x |
|
Regional Management Corp
NYSE:RM
|
0.232x |
|
Omni Bridgeway Ltd
AU:OBL
|
0.027x |
|
Lifezone Metals Limited
NYSE:LZM
|
-0.061x |
Annual Cash Flow Conversion Efficiency for Sarana Meditama Metropolitan (2011–2025)
The table below shows the annual cash flow conversion efficiency of Sarana Meditama Metropolitan from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Sarana Meditama Metropolitan worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Rp4.17 Trillion ≈ $244.10 Million |
Rp357.02 Billion ≈ $20.92 Million |
0.086x | +34.64% |
| 2024-12-31 | Rp4.14 Trillion ≈ $242.49 Million |
Rp263.42 Billion ≈ $15.44 Million |
0.064x | +67.33% |
| 2023-12-31 | Rp3.98 Trillion ≈ $233.42 Million |
Rp151.55 Billion ≈ $8.88 Million |
0.038x | +1481.24% |
| 2022-12-31 | Rp3.98 Trillion ≈ $233.39 Million |
Rp9.58 Billion ≈ $561.51K |
0.002x | -95.80% |
| 2021-12-31 | Rp4.43 Trillion ≈ $259.67 Million |
Rp253.74 Billion ≈ $14.87 Million |
0.057x | +244.24% |
| 2020-12-31 | Rp545.82 Billion ≈ $31.98 Million |
Rp-21.67 Billion ≈ $-1.27 Million |
-0.040x | -120.60% |
| 2019-12-31 | Rp977.50 Billion ≈ $57.28 Million |
Rp188.40 Billion ≈ $11.04 Million |
0.193x | +716.24% |
| 2018-12-31 | Rp1.33 Trillion ≈ $77.70 Million |
Rp31.31 Billion ≈ $1.83 Million |
0.024x | -62.85% |
| 2017-12-31 | Rp1.04 Trillion ≈ $61.07 Million |
Rp66.26 Billion ≈ $3.88 Million |
0.064x | -56.32% |
| 2016-12-31 | Rp850.97 Billion ≈ $49.86 Million |
Rp123.85 Billion ≈ $7.26 Million |
0.146x | +10.60% |
| 2015-12-31 | Rp741.18 Billion ≈ $43.43 Million |
Rp97.53 Billion ≈ $5.71 Million |
0.132x | -77.37% |
| 2014-12-31 | Rp191.08 Billion ≈ $11.20 Million |
Rp111.12 Billion ≈ $6.51 Million |
0.582x | +3.41% |
| 2013-12-31 | Rp133.01 Billion ≈ $7.79 Million |
Rp74.80 Billion ≈ $4.38 Million |
0.562x | -80.36% |
| 2012-12-31 | Rp19.22 Billion ≈ $1.13 Million |
Rp55.04 Billion ≈ $3.23 Million |
2.863x | +137.81% |
| 2011-12-31 | Rp-4.05 Billion ≈ $-237.07K |
Rp30.64 Billion ≈ $1.80 Million |
-7.573x | -- |
About Sarana Meditama Metropolitan
PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. It also is involved in trading of medical equipment; healthcare pharmacy; real estate; and agriculture. The company was founded in 1984 and is based in Jakarta, Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Elang Mahkota Teknologi Tbk.